BWIN

Baldwin is a classic insurance-brokerage roll-up with a genuinely durable top line: revenue has compounded from $567M (FY2021) to $1.49B (FY2025), up 8.5% YoY, with the MD&A attributing ~$98.5M of the gain to organic core-commission growth and $23.6M to partnership activity. Brokerage commissions are recurring, capital-light and high-retention, and operating income actually grew 22% to $73.9M. At a P/S of just 1.2, the equity is priced well below where profitable brokerage peers typically trade, and the GAAP net loss is heavily distorted by $121M of non-cash acquisition amortization (D&A of $128M) — on an adjusted-EBITDA basis the underlying business is solidly profitable. That is the bull case and it is real.

The problem sits below the operating line. The 10-K discloses $1.71B of borrowings ($600M Senior Secured Notes at 7.125%, $1.004B Term Loan at 6.25%, $107M Revolver at 6.39%), and net interest expense of $121.4M more than consumes the entire $73.9M of operating income, producing a $52.8M pre-tax loss and a fifth consecutive year of net losses (-$33.8M FY2025). Liabilities/equity is 4.63x and retained earnings are -$245M. More worrying than the GAAP loss is the cash: operating cash flow swung to -$29.4M (down 157% YoY) against only $124M of cash on hand — a brokerage should be a cash machine, so a negative, deteriorating OCF is the single most important flag in this data.